Skip to content

Study on predicting the risk of postoperative recurrence of rectal cancer after Neoadjuvant chemoradiotherapy based on patho-radiomics related tumor microenvironment heterogeneity

Study on predicting the risk of postoperative recurrence of rectal cancer after Neoadjuvant chemoradiotherapy based on patho-radiomics related tumor microenvironment heterogeneity

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500096138
Enrollment
Unknown
Registered
2025-01-19
Start date
2025-02-01
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Locally Advanced Rectal Cancer(LARC)

Interventions

Observation group:None

Sponsors

The First Affiliated Hospital of Henan University of CM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Pathological biopsy confirmed adenocarcinoma; 2. Diagnosed with LARC (cT3-4 stage, and/or positive lymph node metastasis) by pre NAC MRI, with no evidence of distant metastasis; 3. After NAC, a total mesorectal excision was performed; 4. Receive MRI examination within one week before NAC; 5. Receive MRI examination 8-10 weeks after NAC or within 1 week before surgery; 6. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. NAC incomplete; 2. Incomplete MRI sequence and inability to retrieve postoperative HE stained sections; 3. Previous or concurrent history of other malignant tumors and treatment history such as pelvic radiotherapy and systemic chemotherapy; 4. Surgery more than 12 weeks after NAC; 5. Poor image quality makes image segmentation and feature extraction difficult. 6. During the course of the disease, other local treatments, targeted therapies, or immunotherapy may be received.

Design outcomes

Primary

MeasureTime frame
Recurrence;

Countries

China

Contacts

Public ContactLi Kaiwei

The First Affiliated Hospital of Henan University of CM

likaiweign@163.com+86 187 3606 0102

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026